Related Experiment Video
Updated: Jan 8, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
Published on: June 14, 2020
Basic Science and Pathogenesis
S Dahyun Park1, Cheryl R McCreary1, Myrlene Gee2
1University of Calgary, Calgary, AB, Canada.
Insights
Cerebral amyloid angiopathy (CAA) and Alzheimer's disease (AD) show impaired glymphatic clearance and reduced cerebrovascular reactivity (CVR). These vascular changes in CAA and AD may stem from altered blood flow dynamics rather than dilation capacity.
Area of Science:
- Neuroimaging
- Neurology
- Cerebrovascular diseases
Background:
- Cerebral amyloid angiopathy (CAA) involves amyloid-beta deposition in brain blood vessels, increasing hemorrhage and dementia risk, and is common in Alzheimer's disease (AD).
- Impaired glymphatic clearance and reduced cerebrovascular reactivity (CVR) are hypothesized contributors to amyloid-beta deposition.
- Previous studies have not investigated these factors concurrently in patients with CAA or AD.
Purpose of the Study:
- To investigate glymphatic function and CVR in patients with CAA and AD.
- To explore the relationship between glymphatic function and CVR in these patient groups.
Main Methods:
- MRI including diffusion tensor imaging along the perivascular space (DTI-ALPS) and BOLD imaging with hypercapnic challenge was performed on 43 CAA patients, 16 AD patients, and 53 healthy controls (HC).
- Glymphatic function was quantified using DTI-ALPS, and CVR was measured as the percentage change in BOLD signal per mmHg increase in end-tidal CO2.
- Statistical analyses adjusted for age, sex, and hypertension.
Main Results:
- Patients with CAA and AD exhibited significantly lower DTI-ALPS and CVR compared to HC (p < 0.001).
- No significant association was found between DTI-ALPS and grey matter, white matter, or global CVR in the studied groups.
- CAA and AD participants were predominantly male, older, and had higher hypertension rates than HC.
Conclusions:
- Reduced glymphatic function in CAA and AD is associated with cerebrovascular changes.
- Vascular contributions to impaired glymphatic function in CAA and AD may be linked to altered vasomotion and blood flow pulsatility, not solely dilation capacity.
Background:
Cerebral amyloid angiopathy (CAA) is characterized by deposition of amyloid-beta (Aβ) within the walls of the small blood vessels of the brain and leptomeninges. It causes ∼20% of intracerebral hemorrhage, increases the risk of dementia, and is common in patients with Alzheimer's disease (AD). Deposition of Aβ may result from impaired glymphatic clearance concurrent with a reduction in cerebrovascular reactivity, but this has not been investigated in patients with CAA or AD.
Method:
Patients with CAA (N = 43) and AD (N = 16) patients and healthy controls (HC; N = 53) underwent an MRI at 3T that included a T1-weighted and fluid attenuated inversion recovery (FLAIR) images, diffusion-weighted imaging (30 directions; b-value=1000s/mm2) and BOLD imaging involving a 2-minute hypercapnic challenge (5% inspired CO2). Glymphatic function was quantified by diffusion tensor imaging along the perivascular space (DTI-ALPS; ratio between diffusion in the perivascular space direction and diffusion of free water in the interstitium) while CVR was quantified as the % change in BOLD per mmHg increase in the end-tidal partial pressure of CO2. Group comparisons of DTI-ALPS were adjusted for age and sex while comparisons of CVR were adjusted for age, sex and hypertension. Associations between DTI-ALPS and CVR were adjusted for age, sex, hypertension, white matter hyperintensity volume and group.
Result:
CAA and AD participants were predominantly male whereas HCs were predominantly female (Table). CAA participants were older with a greater prevalence of hypertension. DTI-ALPS was lower in patients with CAA and AD versus HCs (ANCOVA, p <0.001; Figure 1A). Similarly, grey matter (GM), white matter (WM), and global CVR (mean of GM and WM) were lower in CAA and AD compared to HCs (all ANCOVAs, p <0.001; Figure 1B). However, DTI-ALPS was not associated with GM (-0.18 (-0.73 - 0.36), p = 0.504), WM (0.02, -0.84 - 0.89, p = 0.646) or global CVR (-0.15, -0.85 - 0.55, p = 0.94; Figure 2).
Conclusion:
Vascular contributions to reduced glymphatic function in CAA and AD may be more related to changes in vasomotion and pulsatility of blood flow through cerebral vessels than the ability of the cerebrovasculature to dilate.
Related Concept Videos
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Urinary Tract Infection II: Pathophysiology
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pneumonia II: Pathophysiology
Stages of Infection
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

